skip to navigation skip to content
 

Accelerate

These ventures have been with Accelerate Cambridge for over three months and are either looking to finalise their product or close their first sales.

Antiverse

Antiverse is developing a revolutionary technology to predict antibody drug hits in a single day rather than in months through the traditional methods. A combination of cell-free technology and cutting-edge machine learning is used to develop a proprietary model that recognises and predicts features of antibody-antigen interaction. Ultimately, the customers, who are pharma companies and Contract Research Organisations (CROs), provide us with the sequence of the antigen and Antiverse provides the customers with the sequence of antibodies which bind the antigen with a high affinity. A pharma company and several CROs have already expressed a strong interest in using the service and will also provide support to develop the model as rapidly as possible. Antiverse's technology will greatly speed up antibody hit discovery and thus enable the development of more, and better, antibody therapeutics against cancer, inflammation and rare diseases.

Visit the Antiverse website

Antiverse logo

Bond 180

Bond 180 is a fintech startup spun out of the University of Cambridge’s Judge Business School. Middlemen in financial services pocket up to $2 trillion annually. The bond value-chain dominated by banks incentivised by high fees. Bond 180's mission statement is to solve this problem. We are building a two-tiered platform model: An investor-led matching service and a digital bond issuance vehicle using the R3 CORDA blockchain. We are supported by R3 and are actively raising funds to build out the first prototype of our solution.

Visit the Bond 180 website

Bond 180 logo

Cambridge Exercise Technology

Cambridge Exercise Technology is a fitness technology company that uses emerging technologies to innovate on the fitness experience. Our goal is to create a cultural shift in how the world views and interacts with exercise.

Visit the Cambridge Exercise Technology website

Cambridge Exercise Technology logo

Carryr

Carryr is on a mission to supercharge the end-to-end delivery experience for fashion e-commerce.

They do this by partnering up with some of the most exciting retailers and with a simple e-commerce integration, allowing them to offer their online customers a completely flexible delivery experience that no longer disappoints (delivered in as little as 60 minutes or at a time that better suits) - improving the retailer's reputation and, ultimately, their sales.

Visit the Carryr website

Carryr logo

CavPoint

CavPoint develops software tools to reduce the costs of testing automated vehicle technologies. Automated/autonomous vehicles must operate in environments with extremely high levels of variability and it is in practice impossible to test all of these variations before launch. There is the risk that the deployed system will encounter an untested scenario in the field, and not behave appropriately or operate in an unsafe manner. Our machine learning based software actively searches for the combinations of variations where the system has undesirable behaviour so that the issue can be identified and addressed during the development phase. This reduces the overall time and cost of testing, improves the robustness of the deployed system, and accelerates the time to market.

Visit the CavPoint website

CavPoint logo

Congenita

Computationally designed, personalised, three dimensional (3D) models for corrective, congenital cardiac surgery in neonates.

D-Art

D-Art is about smart healthcare for artworks.

Artworks have been built over centuries using materials that deteriorate due to natural ageing, exposure to light and human activities. The conservation process is expensive and time-consuming, limiting its presentation to visitors. The lack of skilled conservators and technologies for conservation has been well-known in the field. Current general solutions to these issues are centred around climate control, which is very expensive and not environmental friendly. It is therefore essential to equip heritage institutes with cheap but effective automatic health check system that can be easily tailored to individual objects.

We provide a system that is easy to deploy and affordable to heritage institutes. It brings together the capacity of image analysis, artificial intelligence and predictive models. Our algorithm can identify damages, track their evolution over time and provide dynamic assessments and recommendations for treatment needs (outputs of predictive models using machine learning techniques). This allows the institutes to put limited curator efforts into artworks that require immediate attention, and to better plan for prompt intervention time. This can greatly reduce operational cost and optimise collection management.

Our team consists of scientific experts in museum studies with over 10 years of combined experiences in imaging, data processing and structural health monitoring. We have a large international network of professional conservators in the largest institutes such as the English Heritage and Wallace Collection (UK), Rijksmuseum (Netherlands) and the Louvres (France).

D-Art logo

eGoodAccess

aGoodAccess is a digital health platform which provides accessible, affordable and effective talking therapies, delivered person-to-person and online.

This digital health service solves some key problems: provides users convenient access to timely help; matches users with the right therapist and reduces the cost of private therapy.

This venture seeks to address a vast unmet need: mental health has the highest disease burden in the UK, more than cancer and cardio vascular diseases. It costs the UK £105 billion, including in lost productivity at work. In addition, three out of four people who need help are not getting it and nine out of ten people with mental health issues suffer stigma and discrimination.

Visit the eGoodAccess website

Egoodaccess logo.

LetsPuddle (formerly Lynk Cambridge)

One to two children in every classroom around the world suffer from chronic headaches. Headaches, such as migraines that persist for over three months. This may lead to anxiety, depression and a disturbed family relationship. Often cure is not possible. Yet, it is possible to teach the children how to cope with pain. Together with pain experts, therapists and charities Puddle develops coping strategies in the format of mobile games and relaxing exercises such as yoga.

Puddle makes coping strategies available to children suffering from migraines, aiming to help all children with any kind of chronic pain in the future. Because no cloud should keep us from playing.

Visit the LetsPuddle website

Kalium Health

Kalium Health is developing the world's first blood potassium test suitable for home use. The test will help chronic kidney patients and suffers of rare diseases to manage their health away from hospitals and clinics, improving health and lifestyles and significantly reducing the costs of healthcare provision. Our team combines world-class clinical, scientific and product development expertise.

Visit the Kalium Health website

Kalium Health logo.

Landable (formerly Project Domus)

Landable is an online real estate company that allows average investors to buy into private residential and commercial properties by pooling their resources through an investment platform. Pooling of capital (or syndication) allows investors to leverage the power of their social network to collectively put their money to work. Our screening and matching technology ensures that all property investments presented on the platform meet a minimum level of quality and all project sponsors are verified.

Visit the Landable website

Landable logo.

MAP Innovation

MAP Innovation is a startup company focused on product development primarily within the logistics industry. We are currently developing our own MAP-Ping™ system which is a synergetic product that could also be adapted for other applications.

The system aims to eradicate asset loss and provide customers with an interface that can be utilised to enhance current logistical systems or provide a platform to develop a new one. Our remit was to develop a low cost system that addresses problems associated with similar products, incorporate the latest technology and employ hardware that is reliable, efficient and ideally maintenance free.

MAP Innovation logo

mySymptoms (formerly SkyGazer Labs)

mySymptoms mission is to improve the health of sufferers of chronic gut conditions by nutrition, lifestyle, and outcome analysis. mySymptoms was one of the first digital health companies to launch a smartphone app - 'mySymptoms' - in the Apple App Store, followed later by an Android version.

After identifying an emerging market for digital health products, mySymptoms then began development of a data platform to facilitate clinical services, academic and medical research, along with more advanced analytics using machine learning. The company is shortly due to launch a pilot of its new clinical app, moving the company firmly into the clinical marketplace. mySymptoms is currently funded by revenues from its smartphone app, mySymptoms, and is privately held by its two founders, Darren Launders and Damian Helme.

Visit the mySymptoms website

mySymptoms logo

NeutroCheck

As chemotherapy suppresses the immune system, even a mild illness can be fatal for chemotherapy patients. The suppression of a white blood cell known as the neutrophil, can lead to neutropenic sepsis, a life-threatening medical emergency. Therefore, chemotherapy patients with even mild signs of infection at home are brought into hospital for blood tests to check their neutrophil levels and, while awaiting results, given intravenous antibiotics as a precaution. Six in 10 patients turn out to have normal neutrophil counts, and therefore did not necessarily need to attend hospital, costing the NHS approximately £40 million each year.

NeutroCheck was launched to develop a transformative new medical device, NeutroCheck, presenting tangible efficiencies in patient care and healthcare resource, both financial and human. The device will be used in the patient’s home to give a near-instant measure of the patient’s neutrophil levels using blood from a small pin-prick. The NeutroCheck device is designed to be portable and easy-to-use in a home environment.

Our focus is to produce a fast, reliable and low-cost device which would improve safety and quality of life for cancer patients worldwide, whilst saving healthcare institutions such as the NHS millions of pounds each year from substantially reducing hospital visits.

NeutroCheck logo

Oculare AI

Oculare AI is a healthcare technology company specialising in eye health. Using AI to analyse eye images in order to detect eye disease, the company helps physicians to treat patients more effectively and efficiently. Oculare AI is focused on prevention of disease, and its technology is designed to regularly monitor patients eye health in order to detect signs of deterioration early so that treatment can take place before problems arise. The company's mission is to help end blindness in the world.

Oculare AI logo.

Oh Lily! (formerly Water LilyPop)

We believe that eating is a necessity, but to eat intelligently is an art!

Oh Lily! is a range of sweet and savoury snacks made from water lily seeds. Water lily seeds have been used for centuries in traditional medicines such as Ayurveda and Chinese medicine for its high nutritional values. Still unknown in the western world, the potential of this plant is underutilised, and we aim to share the benefits of these seeds with our consumers, convinced that it will bring a snacking revolution. Indeed, more and more people are deciding to change their way of eating and choosing different diets. Health has become a priority, but the consumer doesn't want to compromise on the taste, fun or texture. With its snacks, Oh Lily! is gathering all of those criteria to offer a healthy, tasty and crunchy experience. The seeds are naturally gluten-free and free from sugar and all our recipes are vegan, so Oh Lily! fits for all and is good for all.

In our project we aim to work closely with the local farmers and participate to the improvement of their livelihood, we would like to contribute to a more sustainable future for the food industry in term of product, packaging and supply chain.

Our mission is to take the consumer on a conscious culinary journey.

Visit the Oh Lily! website

Oh Lily! logo

Orca Scan

Barcode technology first made its impact on business productivity in the late 1970s, yet due to the complexity and high costs associated with implementing enterprise barcode solutions, the majority of organisations still rely on pen, paper and spreadsheets to manage their assets and inventory.

 

Orca Scan was designed to dramatically simplify, and lower the cost of enterprise barcode solutions to make barcode tracking technology available to all, regardless of company size or budget. They do that by removing the need for expensive hardware and custom software development, by leveraging cloud computing and the smartphone we're all carrying in our pockets.

 

Visit the Orca Scanwebsite

Orca Scan logo

Outfield

Outfield is providing farmers with access to new drone technologies. We are developing a range of innovative services using autonomous aircraft and computer vision systems. Outfield services range from land surveying to horticulture crop management, using systems that are faster, cheaper and more accurate than current field assessment techniques. Outfield is growing the future of precision farming.

Visit the Outfield website

Outfield logo

Pinpoint Oncology

Pinpoint Oncology provides a pharmacogenomic test for cancer treatment

Powdies

Powdies is a powder drink made directly from farmers' surplus fruits and vegetables. Using a low temperature dehydration technology, we turn these over-produced and wonky-looking crops into a tasty and nutritional powder drink. Powdies is rich in natural vitamins, minerals, fibre and contains all five of your five-a-day. We hope to make eating vegetables and fruits enjoyable, convenient and hassle-free for everyone. On top of that, we are making a positive environmental impact by reducing food wastage.

Visit the Powdies website

Powdies logo

QBio

QBio is building a pioneering platform to deliver targeted, personalised antibiotics, faster.

Visit the QBio website

QBio logo

Qureight

Qureight is a clinical data curation and analytics company which works in partnership with healthcare bodies and software developers in the field of artificial intelligence. 

Through advanced infrastructure, coupled with technical and clinical expertise, the company performs annotation and analysis of anonymised data. Qureight exploits the value of data in their entirety and allows testing of machine learning algorithms, by collaborating with drug or technology companies, healthcare and academic institutions.

Qureight's mission is to combine technology and life sciences to generate new knowledge and transform the way we use clinical data.

Qureight logo

ScreenMe

ScreenMe is a team of PhD scientists, medical and nutritional professionals. We believe that everyone should be given access to tailored, scientifically accurate, health related advice and information to live longer, healthier lives at the peak of their potential.

To achieve this, we provide access to health marker and microbiome tests using the latest scientific and technological advances. We then combine our different expertise with individuals’ personal needs to provide bespoke, trustworthy information and advice on nutrition and lifestyle. Our platform goes on to provide tailored grocery shopping to make applying the advice you get as easy as possible. Instead of guessing what your body needs at ScreenMe we tell you.

Screen Me logo.

Skinlync

Skinlync is a platform that will simplify skin wellness through the power of technology and connectivity. Using AI-powered image matching and data analytics technology, Skinlync aims to help individuals suffering from various skin diseases, such as eczema, acne etc., find an effective and sustainable solution by becoming the platform that bridges users with other users of the same medical profile, shares valuable information on alternative treatments and connects users with skin wellness experts, thus creating a community-based skin wellness hub.

Visit the Skinlync website

Skinlync logo

Spectranomy

Spectranomy is developing tools and technologies to transform wireless spectrum management for regulators, operators and vendors in the trillion-dollar 5G+ wireless industry. Our patent-pending systems manage the underlying spectrum resource more efficiently, improving capacity and coverage, and saving money for our customers. In doing so, Spectranomy will benefit society as a whole.

Visit the Spectranomy website

Spectranomy logo

Spliceor Therapeutics

Spliceor Therapeutics is an early stage research and development biotechnology company based on translational medical research in Professor Andrew Lever's laboratory in the Department of Medicine, University of Cambridge.

Co-founded by Dr Carin Ingemarsdotter and Professor Lever, the proposed business aims at developing novel curative treatments for certain types of aggressive cancers that do not respond well to current treatment. Our therapeutics are based on a gene-therapy platform technology and we have identified a common mechanism for therapeutic development against liver cancer and pancreatic cancer, successful treatment of which are major unmet medical needs. Our technology is applicable to many other malignancies. Our mission is to provide curative and easily tolerated gene therapies to cancer patients.

Sliceor Therapeutics logo

TheMoment

TheMoment has developed a novel approach to improving symptoms and quality of life for people with Parkinson's disease. Despite optimal medical management many people with Parkinson's continue to suffer with symptoms limiting their quality of life.

TheMoment have in collaboration with people with Parkinson's created a non-invasive wearable device which modulates the sensory dysfunction seen in Parkinson's disease to support improved movement.

We hope to make this novel approach widely available to people with Parkinson's and are excited about the potential for this technology to impact other important neurological conditions.

Visit The Moment website

The Moment logo

Unlimitech

Unlimitech is a Cambridge-based data startup developing a platform technology to help people optimise fitness and nutrition.

Unlimitech is precision fitness tracking, unleashed.

Visit the Unlimitech website

Unlimitech logo